Lance Weathers, MD
Cardiovascular Disease · Rogers, ARNPI 1902086119
Payments from drug & device makers
Across 414 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$760
- Novartis$668
- Pfizer$521
- Amgen$457
- Johnson & Johnson$424
- plus $3K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 78 | $2,046 |
| Medtronic(2 entities) | 44 | $760 |
| Novartis | 47 | $668 |
| Pfizer | 37 | $521 |
| Amgen | 29 | $457 |
| Johnson & Johnson | 55 | $424 |
| Edwards Lifesciences | 7 | $424 |
| Heartflow, Inc. | 3 | $239 |
| Merck | 14 | $222 |
| Boston Scientific | 4 | $213 |
| Amarin Pharma, Inc. | 8 | $166 |
| Boehringer Ingelheim | 12 | $166 |
| AstraZeneca | 11 | $161 |
| Philips North America LLC | 5 | $113 |
| Abiomed | 3 | $112 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $99 |
| Inari Medical, Inc. | 4 | $83 |
| Bayer | 4 | $79 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $76 |
| Sanofi-aventis U.S. LLC | 5 | $74 |
| Novo Nordisk | 4 | $63 |
| Regeneron Healthcare Solutions, Inc. | 4 | $54 |
| Cordis US CORP. | 2 | $48 |
| Esperion Therapeutics, Inc. | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Scpharmaceuticals Inc. | 2 | $41 |
| Baxter Healthcare | 2 | $41 |
| Biosense Webster, Inc. | 1 | $32 |
| Atricure, Inc. | 1 | $31 |
| Cathworks, Inc. | 1 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Biotronik Inc. | 1 | $24 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Bridgebio Pharma, Inc. | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Sanofi | 1 | $14 |
| Cardiva Medical, Inc. | 1 | $12 |
| Gilead | 1 | $12 |
| Chiesi USA, Inc. | 1 | $11 |
How this compares
$7,700 in reported general payments places this provider in the 65th percentile of 130 cardiovascular disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Rogers
- Amr El-ShafeiRogers$81K
- Kiran KurichetyRogers$9K
- Philip RileyRogers$8K
- Larry WeathersRogers$6K
- Robert StuppyRogers$5K
- Ian CawichLittle Rock$1.1M
- Christian Assad KottnerLittle Rock$670K
- Barry UretskyLittle Rock$609K
- Maximiliano ArroyoJonesboro$553K
- William RollefsonLittle Rock$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.